MACULAR CHOROIDAL VOLUME CHANGES AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.

Palkovits, Stefan

MACULAR CHOROIDAL VOLUME CHANGES AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION. [electronic resource] - Retina (Philadelphia, Pa.) Dec 2017 - 2262-2268 p. digital

Publication Type: Journal Article

1539-2864

10.1097/IAE.0000000000001480 doi


Aged
Aged, 80 and over
Angiogenesis Inhibitors--administration & dosage
Bevacizumab--administration & dosage
Choroid--pathology
Dose-Response Relationship, Drug
Drug Administration Schedule
Fluorescein Angiography--methods
Follow-Up Studies
Fundus Oculi
Humans
Intravitreal Injections
Macula Lutea--pathology
Middle Aged
Organ Size
Prospective Studies
Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors
Time Factors
Tomography, Optical Coherence--methods
Treatment Outcome
Visual Acuity
Wet Macular Degeneration--diagnosis